Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AAVCAGsCD59 in Advanced Dry AMD With Geographic Atrophy
NCT04358471Phase 2Withdrawn
- Sponsor
- Hemera Biosciences
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
01
Overview
A Phase 2 trial of JNJ-81201887 in geographic atrophy (GA), sponsored by Hemera Biosciences. Planned start Jul 2021; status: withdrawn.
02
Drugs
JNJ-81201887
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT04358471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04358471.